Plandai Biotechnology Inc (PLPL)

[MNK3240]

SEC did not validate or even talked about Puriblood deal/LOI. They simply waived the old interest penalties and they did not even refer to the reasons behind. PLPL put both things (interest waiver and new plans) in one PR and that somehow sounded to you that SEC confirmed the deal or talked about Puriblood.

I suggest you go read that PR again. Remember, it’s their PR, not SEC’s document.

I am not saying good or bad, this is just to address your assumptions (wrong??) that somehow SEC validated/talked about Puriblood.